Taken together, these results suggest that knocking down IL-4Rα at the chronic phase of experimental schistosomiasis considerably skews the host immune response away from the type 2 arm of the immune response, fosters a qualitatively more regulatory, anti-inflammatory and anti-fibrotic profile with no deleterious effect on host survival. Here, IL4R is linked to schistosomiasis.